BETRF (BetterLife Pharma) EBITDA Margin %: 0.00% (As of Apr. 2026)


BETRF BetterLife Pharma Inc BETRF
28 GF Score
Price $0.11
! 2 Warning Signs
View Full Analysis

What is BetterLife Pharma EBITDA Margin %?

BetterLife Pharma BETRF -1.08% 28 EBITDA Margin % is 0.00% as of Apr. 2026. GuruFocus rates BETRF with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 942 Biotechnology companies, BetterLife Pharma ranks worse than 106157.01% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. BetterLife Pharma's EBITDA for the three months ended in Apr. 2026 was $-0.42 Mil. BetterLife Pharma's Revenue for the three months ended in Apr. 2026 was $0.00 Mil. Therefore, BetterLife Pharma's EBITDA margin for the quarter that ended in Apr. 2026 was 0.00%.

BetterLife Pharma  (OTCPK:BETRF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

BetterLife Pharma EBITDA Margin % Related Terms

BetterLife Pharma EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for BetterLife Pharma's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BetterLife Pharma EBITDA Margin % Chart

BetterLife Pharma Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BetterLife Pharma Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Jan26 Apr26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BETRF vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, BetterLife Pharma's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BetterLife Pharma EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's EBITDA Margin % falls into.


BETRF
28GF Score
BetterLife Pharma Inc BETRF
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BetterLife Pharma EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

BetterLife Pharma's EBITDA Margin % for the fiscal year that ended in Jan. 2026 is calculated as

EBITDA Margin %=EBITDA (A: Jan. 2026 )/Revenue (A: Jan. 2026 )
=-0.93/0
= %

BetterLife Pharma's EBITDA Margin % for the quarter that ended in Apr. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Apr. 2026 )/Revenue (Q: Apr. 2026 )
=-0.424/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
BetterLife Pharma (BETRF) has a EBITDA Margin % of 0.00% as of Apr. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BetterLife Pharma and its competitors. According to the industry distribution chart, BetterLife Pharma ranks #999999 out of 942 companies in the Biotechnology industry.
Is BetterLife Pharma's EBITDA Margin % too high?
BetterLife Pharma's current EBITDA Margin % is 0.00%. Based on the distribution chart, BetterLife Pharma ranks #999999 out of 942 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, BetterLife Pharma has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does BetterLife Pharma's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BetterLife Pharma ranks #999999 out of 942 companies for EBITDA Margin %. This places BetterLife Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BetterLife Pharma and its competitors. BetterLife Pharma's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BetterLife Pharma stock overvalued right now?
BetterLife Pharma (BETRF) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. BetterLife Pharma's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For BetterLife Pharma (BETRF), the current EBITDA Margin % is 0.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BetterLife Pharma Business Description

Other Exchanges NPAU:GermanyBETR:Canada
Address 1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.
28GF Score

Get the complete analysis for BETRF

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price